IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.3550
+0.0100 (2.90%)
Oct 19, 2026, 2:55 PM CET
IDL Diagnostics AB Market Cap
IDL Diagnostics AB has a market cap or net worth of 81.78 million as of October 19, 2026. It is the 42,783rd most valuable company in the world and the 629th biggest in Sweden. Its market cap has decreased by 3.01% in one year.
Market Cap
81.78M
Enterprise Value
58.62M
Revenue
58.95M
Global Rank
Country Rank
#629 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since May 25, 2011, IDL Diagnostics AB's market cap has increased from 16.78M to 81.78M, an increase of 387.42%. That is a compound annual growth rate of 10.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 81.78M | 0.57% |
| Dec 30, 2025 | 81.32M | -9.49% |
| Dec 30, 2024 | 89.84M | -10.76% |
| Dec 29, 2023 | 100.67M | -29.52% |
| Dec 30, 2022 | 142.82M | 31.17% |
| Dec 30, 2021 | 108.88M | -38.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 151.87B |
| Getinge AB | 71.25B |
| Sectra AB | 61.04B |
| Medicover AB | 40.65B |
| Nanologica AB | 85.81M |
| Active Biotech AB | 82.64M |
| Boule Diagnostics AB | 80.00M |
| Vivesto AB | 79.82M |